A comparative study of propranolol versus silver nitrate cautery in the treatment of recurrent primary epistaxis in children

Figures & data

Table 1 Sex distribution among different age groups in studied patients

Age groups (years)	Male (n)	Female (n)
6 to <7	8	7
7 to <8	9	8
8 to <9	10	7
9 to <10	9	9
10 to <11	8	8
11 to 12	10	7

Table 2 Some studied variables among propranolol treatment group

Number of patients	Age group (years)	Treatment duration (weeks)	Rhinoscopy findings	Epistaxis recurrencea
10	6 to <7	3	Bilateral prominent vessels on the anterior nasal septum	One case after discontinuation of treatment
9	7 to <8	2	Normal findings	One case in the last month
7	8 to <9	2	Unilateral dilated vessels on anterior nasal septum	One case in the last month
8	9 to <10	3	Bilateral prominent vessels on the anterior nasal septum	One case in the second month
7	10 to <11	3	Bilateral prominent vessels on the anterior nasal septum	One case after discontinuation of treatment
9	11 to <12	4	Bilateral prominent vessels on the anterior nasal septum	Two cases within the third month

Note:

a Within the 6 month follow-up period after initial enrolment to the study.

Table 3 Some studied variables among silver nitrate cautery treatment group

Number of patients	Age group (years)	Rhinoscopy findings	Epistaxis recurrencea
9	6 to <7	Unilateral dilated vessels on the anterior nasal septum	One case in the third month
10	7 to <8	Unilateral crusting	One case in the first month
8	8 to <9	Unilateral crusting	No recurrence
7	9 to <10	Bilateral prominent vessels on the anterior nasal septum	One case of severe bleeding in the first week
8	10 to <11	Bilateral prominent vessels on the anterior nasal septum	Two cases in the last month
8	11 to <12	Bilateral prominent vessels on the anterior nasal septum	One case after 4 months

Note:

a Within the 6 month follow-up period after initial enrolment to the study.

Table 4 Comparison of rate of epistaxis recurrence in propranolol treatment group and silver nitrate cautery treatment group

P-value	Silver nitrate cautery treatment group	Propranolol treatment group	Variables
NS	50	50	Total number of patients
NS	6 (12%)	7 (14%)	Recurrence of epistaxisa (number of cases)

Notes: NS, nonsignificant (P>0.05).

a Within the 6 month follow-up period after initial enrolment to the study.